DRUG SURVIVAL AND CLINICAL EFFICACY OF 7 YEARS ETANERCEPT TREATMENT IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS FROM THE GLAS COHORT

被引：1
|
作者：
Arends, S. [1 ,2 ]
Brouwer, E. [1 ]
Wink, F. [2 ]
Bos, R. [2 ]
Maas, F. [1 ]
Bootsma, H. [1 ]
van der Veer, E. [3 ]
Spoorenberg, A. [1 ,2 ]
机构：
[1] Univ Med Ctr Groningen, Rheumatol & Clin Immunol, Groningen, Netherlands
[2] Med Ctr Leeuwarden, Rheumatol, Leeuwarden, Netherlands
[3] Univ Med Ctr Groningen, Lab Med, Groningen, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.4990
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0239
引用
收藏
页码：283 / 283
页数：1
相关论文
共 50 条
  • [1] Comparison of drug survival and clinical outcome in patients with ankylosing spondylitis treated with etanercept or adalimumab
    Ruwaard, J.
    l'Ami, M. J.
    Marsman, A. F.
    Kneepkens, E. L.
    van Denderen, J. C.
    van der Horst-Bruinsma, I. E.
    Nurmohamed, M. T.
    Wolbink, G.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (02) : 122 - 126
  • [2] Long-term drug survival and clinical effectiveness of etanercept treatment in patients with ankylosing spondylitis in daily clinical practice
    Arends, S.
    Brouwer, E.
    Efde, M.
    van der Veer, E.
    Bootsma, H.
    Wink, F.
    Spoorenberg, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (01) : 61 - 68
  • [3] Observation of Clinical Efficacy of Etanercept and Infliximab in Patients with Ankylosing Spondylitis
    Zhang, Fengfei
    Sun, Qingzeng
    Qi, Yudong
    Shen, Yang
    Shi, Yingchun
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 126 : 426 - 427
  • [4] Persistent clinical response in patients with ankylosing spondylitis after 4 years of treatment with etanercept
    Baraliakos, Xenofon
    Listing, Joachim
    Song, In-Ho
    Haibel, Hildrun
    Rudwaleit, Martin
    Sieper, Joachim
    Braun, Juergen
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 : 41 - 41
  • [5] A decade of Etanercept - results of a clinical trial in patients with acitve ankylosing spondylitis
    Haibel, H.
    Baraliakos, X.
    Listing, J.
    Fritz, C.
    Braun, J.
    Sieper, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 126 - 127
  • [6] REDUCTION IN SPINAL RADIOGRAPHIC PROGRESSION IN ANKYLOSING SPONDYLITIS PATIENTS RECEIVING PROLONGED TREATMENT WITH TNF INHIBITORS: RESULTS FROM THE GLAS COHORT
    Maas, F.
    Arends, S.
    Brouwer, E.
    Essers, I.
    van der Veer, E.
    Efde, M.
    van Ooijen, P. M.
    Wolf, R.
    Veeger, N. J.
    Bootsma, H.
    Wink, F. R.
    Spoorenberg, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 805 - 805
  • [7] SPINAL RADIOGRAPHIC PROGRESSION DURING 6 YEARS OF TNF-ALPHA BLOCKING THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS FROM THE GLAS COHORT
    Maas, F.
    Spoorenberg, A.
    Brouwer, E.
    Bos, R.
    Efde, M.
    Chaudhry, R. N.
    Veeger, N. J.
    Bootsma, H.
    van der Veer, E.
    Arends, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 716 - 717
  • [8] LONG-TERM OUTCOME OF PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS WITH ETANERCEPT - SUSTAINED EFFICACY AND SAFETY AFTER 7 YEARS
    Baraliakos, X.
    Haibel, H.
    Fritz, C.
    Listing, J.
    Heldmann, F.
    Braun, J.
    Sieper, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : 638 - 638
  • [9] Long term efficacy and safety results and patient reported outcomes in patients with ankylosing spondylitis treated with etanercept for 4 years
    Dijkmans, B. A. C.
    Sieper, J.
    van der Linden, S.
    Martin-Mola, E.
    Leirisalo-Repo, M.
    Singh, A.
    Freundlich, B.
    Koenig, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 395 - 395
  • [10] COMPARISON OF LONG-TERM DRUG SURVIVAL OUTCOME WITH ETANERCEPT TREATMENT AND ADALIMUMAB TREATMENT OF ANKYLOSING SPONDYLITIS
    Ruwaard, J.
    I'Ami, M.
    Marsman, A.
    Kneepkens, E.
    van der Horst-Bruinsma, I. E.
    van Denderen, C.
    Nurmohamed, M. T.
    Wolbink, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 813 - 813
12345